(Q34658897)

English

Prospective, randomized, controlled clinical study evaluating the efficacy of Rheopheresis for dry age-related macular degeneration. Dry AMD treatment with Rheopheresis Trial-ART.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Prospective, randomized, controlled clinical study evaluating the efficacy of Rheopheresis for dry age-related macular degeneration. Dry AMD treatment with Rheopheresis Trial-ART. (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

author name string

Michael Janusz Koss

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Peter Kurz

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Theoharis Tsobanelis

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Walter Lehmacher

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Cordula Fassbender

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Reinhard Klingel

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Frank H J Koch

7

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

publication date

23 July 2009

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Graefe's Archive for Clinical and Experimental Ophthalmology

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

247

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1297-1306

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

https://scigraph.springernature.com/pub.10.1007/s00417-009-1113-7

0 references

Antioxidants, zinc, and age-related macular degeneration: results and recommendations

1 reference

https://api.crossref.org/works/10.1007%2FS00417-009-1113-7

21 January 2018

Rheopheresis for age-related macular degeneration: clinical results and putative mechanism of action

1 reference

https://api.crossref.org/works/10.1007%2FS00417-009-1113-7

21 January 2018

Effect of aging on foveolar choroidal circulation

1 reference

https://api.crossref.org/works/10.1007%2FS00417-009-1113-7

21 January 2018

Visual function and subjective quality of life compared in subjects with acquired macular disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19629514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19629514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rheopheresis in patients with critical limb ischemia--results of an open label prospective pilot trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19629514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rheopheresis for idiopathic sudden hearing loss: results from a large prospective, multicenter, randomized, controlled clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19629514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19629514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/19629514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicenter prospective, randomized, double-masked, placebo-controlled study of Rheopheresis to treat nonexudative age-related macular degeneration: interim analysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19629514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence and progression rates of age-related maculopathy: the Rotterdam Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19629514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rheopheresis in patients with ischemic diabetic foot syndrome: results of an open label prospective pilot trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19629514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced foveolar choroidal blood flow in eyes with increasing AMD severity

1 reference

https://pubmed.ncbi.nlm.nih.gov/19629514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How big is the burden of visual loss caused by age related macular degeneration in the United Kingdom?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19629514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical efficacy of haemorheological treatment using plasma exchange, selective adsorption and membrane differential filtration in maculopathy, retinal vein occlusion and uveal effusion syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/19629514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of age-related macular degeneration in the United States

1 reference

https://pubmed.ncbi.nlm.nih.gov/19629514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quality of life in patients with idiopathic sudden hearing loss: comparison of different therapies using the Medical Outcome Short Form (36) Health Survey questionnaire.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19629514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Foveolar choroidal blood flow in age-related macular degeneration.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19629514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19629514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preliminary analysis of the final multicenter investigation of rheopheresis for age related macular degeneration (AMD) trial (MIRA-1) results.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19629514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of membrane differential filtration on the natural course of age-related macular degeneration: a randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19629514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rheopherese® bei altersbedingter Makuladegeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/19629514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rheopheresis: rheologic, functional, and structural aspects

1 reference

https://pubmed.ncbi.nlm.nih.gov/19629514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rheophoresis. A systematic approach to therapy of age-related macular degeneration (AMD)?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19629514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improvement of macular function by membrane differential filtration in diabetic retinopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19629514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural course in fellow eyes of patients with unilateral age-related exudative maculopathy. A fluorescein angiographic 4-year follow-up of 45 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19629514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence of blindness in southern Germany due to glaucoma and degenerative conditions.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19629514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8

1 reference

https://pubmed.ncbi.nlm.nih.gov/19629514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of genetic factors and inflammation in age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/19629514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00417-009-1113-7

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34658897&oldid=1403766991"